Literature DB >> 24210841

Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis.

Jinny E Chang1, Taylor A Doherty2, Rachel Baum2, David Broide3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24210841      PMCID： PMC3943597          DOI： 10.1016/j.jaci.2013.09.020

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  12 in total

1.  Systemically dispersed innate IL-13-expressing cells in type 2 immunity.

Authors:  April E Price; Hong-Erh Liang; Brandon M Sullivan; R Lee Reinhardt; Chris J Eisley; David J Erle; Richard M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP.

Authors:  F G Gervais; R P Cruz; A Chateauneuf; S Gale; N Sawyer; F Nantel; K M Metters; G P O'neill
Journal:  J Allergy Clin Immunol       Date:  2001-12       Impact factor: 10.793

3.  Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells.

Authors:  Kazuyo Moro; Taketo Yamada; Masanobu Tanabe; Tsutomu Takeuchi; Tomokatsu Ikawa; Hiroshi Kawamoto; Jun-Ichi Furusawa; Masashi Ohtani; Hideki Fujii; Shigeo Koyasu
Journal:  Nature       Date:  2009-12-20       Impact factor: 49.962

4.  Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.

Authors:  Jenny M Mjösberg; Sara Trifari; Natasha K Crellin; Charlotte P Peters; Cornelis M van Drunen; Berber Piet; Wytske J Fokkens; Tom Cupedo; Hergen Spits
Journal:  Nat Immunol       Date:  2011-09-11       Impact factor: 25.606

5.  An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro.

Authors:  Hiromi Sugimoto; Michitaka Shichijo; Takashi Iino; Yoshihisa Manabe; Akihiko Watanabe; Makoto Shimazaki; Florian Gantner; Kevin B Bacon
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

6.  A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils.

Authors:  J F Royer; P Schratl; J J Carrillo; R Jupp; J Barker; C Weyman-Jones; R Beri; C Sargent; J A Schmidt; D Lang-Loidolt; A Heinemann
Journal:  Eur J Clin Invest       Date:  2008-09       Impact factor: 4.686

7.  STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria.

Authors:  Taylor A Doherty; Naseem Khorram; Jinny E Chang; Hee-Kyoo Kim; Peter Rosenthal; Michael Croft; David H Broide
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-03       Impact factor: 5.464

Review 8.  Type 2 innate lymphoid cells: new players in asthma and allergy.

Authors:  Seth T Scanlon; Andrew N J McKenzie
Journal:  Curr Opin Immunol       Date:  2012-09-15       Impact factor: 7.486

9.  Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus.

Authors:  Laurel A Monticelli; Gregory F Sonnenberg; Michael C Abt; Theresa Alenghat; Carly G K Ziegler; Travis A Doering; Jill M Angelosanto; Brian J Laidlaw; Cliff Y Yang; Taheri Sathaliyawala; Masaru Kubota; Damian Turner; Joshua M Diamond; Ananda W Goldrath; Donna L Farber; Ronald G Collman; E John Wherry; David Artis
Journal:  Nat Immunol       Date:  2011-11       Impact factor: 25.606

10.  Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2.

Authors:  H Hirai; K Tanaka; O Yoshie; K Ogawa; K Kenmotsu; Y Takamori; M Ichimasa; K Sugamura; M Nakamura; S Takano; K Nagata
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307
View more
  61 in total

1.  Pathways to limit group 2 innate lymphoid cell activation.

Authors:  Taylor A Doherty; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2017-01-10       Impact factor: 10.793

Review 2.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

Review 3.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

Review 4.  At the bedside: the emergence of group 2 innate lymphoid cells in human disease.

Authors:  R Stokes Peebles
Journal:  J Leukoc Biol       Date:  2014-12-16       Impact factor: 4.962

Review 5.  Group 2 innate lymphoid cells in health and disease.

Authors:  Brian S Kim; David Artis
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-08       Impact factor: 10.005

Review 6.  Innate lymphoid cells: major players in inflammatory diseases.

Authors:  Mikaël Ebbo; Adeline Crinier; Frédéric Vély; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2017-08-14       Impact factor: 53.106

Review 7.  Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.

Authors:  Monica G Lawrence; John W Steinke; Larry Borish
Journal:  Ann Allergy Asthma Immunol       Date:  2016-08       Impact factor: 6.347

Review 8.  Update on Aspirin-Exacerbated Respiratory Disease.

Authors:  Katharine M Woessner
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

9.  Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84.

Authors:  Taylor A Doherty; David Scott; Hannah H Walford; Naseem Khorram; Sean Lund; Rachel Baum; Jinny Chang; Peter Rosenthal; Andrew Beppu; Marina Miller; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

Review 10.  Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.

Authors:  Maya R Karta; David H Broide; Taylor A Doherty
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.